Li C, Chen X, Wu J, Heng S, et al. High-throughput screening identified pacritinib as a promising therapeutic approach to overcome lenvatinib resistance in hepatocellular carcinoma by targeting IRAK1. Biochem Biophys Res Commun 2024;734:150782.
PMID: 39378786